Global Tissue Sealants Medical Device Pipeline Market Landscape Report 2021: Stage of Development, Segment, Regulatory Path, Estimated Approval Date, Ongoing Clinical Trials - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Tissue Sealants - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.

"Tissue Sealants - Medical Devices Pipeline Product Landscape, 2021' provides comprehensive information about the Tissue Sealants pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Tissue sealants serve primarily as a physical barrier to prevent leakage of fluid and/or gas from a surgical incision. They can be used to hold the flaps of internal organs together, to seal the blood vessels in case of injury/surgery or as an adjunct with hemostatic agents.

Scope

• Extensive coverage of the Tissue Sealants under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Tissue Sealants and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Tissue Sealants under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Tissue Sealants Overview

3 Products under Development

3.1 Tissue Sealants - Pipeline Products by Stage of Development

3.2 Tissue Sealants - Pipeline Products by Segment

3.3 Tissue Sealants - Pipeline Products by Territory

3.4 Tissue Sealants - Pipeline Products by Regulatory Path

3.5 Tissue Sealants - Pipeline Products by Estimated Approval Date

3.6 Tissue Sealants - Ongoing Clinical Trials

4 Tissue Sealants - Pipeline Products under Development by Companies

4.1 Tissue Sealants Companies - Pipeline Products by Stage of Development

4.2 Tissue Sealants - Pipeline Products by Stage of Development

5 Tissue Sealants Companies and Product Overview

6 Tissue Sealants- Recent Developments

7 Appendix

Companies Mentioned

• Adhesys Medical GmbH
• Advanced Medical Solutions Group plc
• Aleo BME Inc
• Angiotech Pharmaceuticals Inc
• Arch Therapeutics Inc
• Arizona State University
• Baxter International Inc
• Biomedica Management Corp
• Boston University
• Calmare Therapeutics Inc
• Clemson University
• Cohera Medical Inc
• Covalent Medical, Inc. (Inactive)
• CR Bard Inc
• DSM Biomedical BV
• Eidgenossische Materialprufungs- und Forschungsanstalt
• Elastagen Pty Ltd
• Ethicon Endo-Surgery Inc
• Gamma Therapeutics Inc
• GATT Technologies BV
• Hemostasis LLC
• HyperBranch Medical Technology Inc
• Institute of Molecular Biology of Parana
• InVivo Therapeutics Corp
• Johns Hopkins University
• Kollodis BioSciences Inc
• Kuros Biosciences AG
• Laser Tissue Welding, Inc.
• Medisse BV (Inactive)
• Meril Life Sciences Pvt Ltd
• Nurami Medical Ltd
• Pharming Group NV
• Polyganics BV
• Protein Polymer Technologies Inc (Inactive)
• Purdue University
• Samyang Biopharmaceuticals Corp
• Sealantis Ltd.
• Shanghai Haohai Biological Technology Co Ltd
• Surgical Sealants, Inc.
• Teijin Pharma Ltd
• Texas A&M University
• The Medicines Co
• Tissium SA
• University of Akron

For more information about this report visit https://www.researchandmarkets.com/r/x37b2b

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900